Medtronic has received FDA clearance for a mobile app that allows patients to remotely forward data from their pacemakers with their physicians. The app is paired with a device, the MyCareLink Smart ...

Clinicians have been able to remotely monitor pacemakers for years thanks to a combination of near-field and remote wireless technologies, but until now, patients haven’t been able to access the data ...

DEFINE AFib Study Will Leverage Data from Medtronic Insertable Cardiac Monitors and Medtronic Discovery App™ with the Goal of Informing Atrial Fibrillation (AF) Management Strategies DUBLIN, June 29, ...

With the launch on Tuesday of its MyCareLink Heart mobile app, Medtronic has officially created the world’s first smartphone-connected pacemaker. The app pairs with Medtronic BlueSync pacemakers, and ...

Roughly 5,000 Apple iPads being used within Medtronic have kept the IT organization at the world’s largest medical device company pretty busy developing apps. And now, four months into the launch of ...

Medtronic has received FDA 510(k) clearance for its MiniMed Connect device, which allows users of Medtronic's continuous glucose monitor (CGM) and insulin pump to view data from those devices on their ...

With a new smartphone app clearance from the FDA, Medtronic said it has all the pieces necessary to deliver a complete diabetes management system aimed at people taking multiple insulin injections per ...

The artificial intelligence-powered Sugar.IQ diabetes assistant app can help patients stay within optimal glycemic range for longer periods of time and significantly reduce hypoglycemic events, ...

With the COVID-19 pandemic still making it difficult to initiate studies in research centers, virtual clinical studies have become all the rage—and Medtronic is hopping on the bandwagon. The medtech ...

Medtronic and IBM have data showing that the combination of a continuous glucose monitoring system and Suger.IQ app enables diabetics to stay their time in optimal glycemic range for an extra hour a ...

At Samsung Developer Conference 2019 today, Medtronic and Samsung showed off a Galaxy smartphone app, Patient Programmer, that allows patients to manage their own therapy for Parkinson’s disease.

DUBLIN, -- Medtronic plc, the global leader in medical technology, today announced the initiation of the DEFINE AFib study, the company's first app-based research study. Using data collected from the ...